nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—DRD1—nerve—skin cancer	0.0776	0.107	CbGeAlD
Minaprine—HTR2A—hindlimb—skin cancer	0.0497	0.0686	CbGeAlD
Minaprine—MAOA—nerve—skin cancer	0.0463	0.064	CbGeAlD
Minaprine—DRD2—nerve—skin cancer	0.0458	0.0633	CbGeAlD
Minaprine—HTR2A—appendage—skin cancer	0.0426	0.0589	CbGeAlD
Minaprine—HTR2A—nerve—skin cancer	0.0302	0.0417	CbGeAlD
Minaprine—MAOA—nipple—skin cancer	0.0263	0.0363	CbGeAlD
Minaprine—MAOA—neck—skin cancer	0.026	0.0359	CbGeAlD
Minaprine—HTR2A—endothelium—skin cancer	0.0257	0.0355	CbGeAlD
Minaprine—HTR2A—blood vessel—skin cancer	0.0237	0.0328	CbGeAlD
Minaprine—HTR2B—skin of body—skin cancer	0.0206	0.0284	CbGeAlD
Minaprine—MAOA—connective tissue—skin cancer	0.0187	0.0258	CbGeAlD
Minaprine—DRD1—head—skin cancer	0.0184	0.0254	CbGeAlD
Minaprine—HTR2C—female reproductive system—skin cancer	0.0171	0.0236	CbGeAlD
Minaprine—HTR2A—neck—skin cancer	0.017	0.0234	CbGeAlD
Minaprine—SLC6A4—female reproductive system—skin cancer	0.0162	0.0224	CbGeAlD
Minaprine—CHRM1—female reproductive system—skin cancer	0.0162	0.0223	CbGeAlD
Minaprine—HTR2B—female reproductive system—skin cancer	0.0161	0.0222	CbGeAlD
Minaprine—MAOA—mammalian vulva—skin cancer	0.0154	0.0212	CbGeAlD
Minaprine—HTR2C—head—skin cancer	0.0143	0.0197	CbGeAlD
Minaprine—ACHE—lymph node—skin cancer	0.014	0.0194	CbGeAlD
Minaprine—SLC6A4—head—skin cancer	0.0136	0.0187	CbGeAlD
Minaprine—CHRM1—head—skin cancer	0.0135	0.0186	CbGeAlD
Minaprine—HTR2B—head—skin cancer	0.0134	0.0185	CbGeAlD
Minaprine—MAOA—female reproductive system—skin cancer	0.0132	0.0182	CbGeAlD
Minaprine—HTR2A—connective tissue—skin cancer	0.0122	0.0168	CbGeAlD
Minaprine—HTR2A—epithelium—skin cancer	0.0116	0.0159	CbGeAlD
Minaprine—MAOA—head—skin cancer	0.011	0.0152	CbGeAlD
Minaprine—DRD2—head—skin cancer	0.0109	0.015	CbGeAlD
Minaprine—HTR2B—lymph node—skin cancer	0.0094	0.013	CbGeAlD
Minaprine—HTR2A—female reproductive system—skin cancer	0.00858	0.0118	CbGeAlD
Minaprine—CYP2D6—female reproductive system—skin cancer	0.00782	0.0108	CbGeAlD
Minaprine—MAOA—lymph node—skin cancer	0.0077	0.0106	CbGeAlD
Minaprine—HTR2A—head—skin cancer	0.00717	0.0099	CbGeAlD
Minaprine—CYP2D6—head—skin cancer	0.00653	0.00902	CbGeAlD
Minaprine—HTR2B—GPCR downstream signaling—MC1R—skin cancer	0.000788	0.00286	CbGpPWpGaD
Minaprine—MAOA—Transmission across Chemical Synapses—BRAF—skin cancer	0.000768	0.00279	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—SMO—skin cancer	0.00076	0.00276	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—PTCH1—skin cancer	0.00076	0.00276	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—MC1R—skin cancer	0.000743	0.0027	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—PTGER4—skin cancer	0.00074	0.00269	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—MC1R—skin cancer	0.000716	0.0026	CbGpPWpGaD
Minaprine—CHRM1—Regulation of Actin Cytoskeleton—BRAF—skin cancer	0.00071	0.00258	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—SHH—skin cancer	0.000708	0.00257	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—PTCH2—skin cancer	0.000705	0.00256	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—SHH—skin cancer	0.000696	0.00253	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—PTCH2—skin cancer	0.000694	0.00252	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—SHH—skin cancer	0.000693	0.00251	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—PTCH2—skin cancer	0.00069	0.0025	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	0.000683	0.00248	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—MC1R—skin cancer	0.000675	0.00245	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—SMO—skin cancer	0.000671	0.00244	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—PTCH1—skin cancer	0.000671	0.00244	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PLIN2—skin cancer	0.000666	0.00242	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—PTCH1—skin cancer	0.00066	0.0024	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—SMO—skin cancer	0.00066	0.0024	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—PTCH1—skin cancer	0.000657	0.00238	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—SMO—skin cancer	0.000657	0.00238	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—PTGER4—skin cancer	0.000653	0.00237	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—CDK4—skin cancer	0.000645	0.00234	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—PTGER4—skin cancer	0.000643	0.00233	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—PTGER4—skin cancer	0.000639	0.00232	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—MC1R—skin cancer	0.000636	0.00231	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—CDK4—skin cancer	0.000632	0.00229	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PLIN2—skin cancer	0.000627	0.00228	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—BRAF—skin cancer	0.000625	0.00227	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—BRAF—skin cancer	0.000589	0.00214	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PTCH2—skin cancer	0.000585	0.00212	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—MC1R—skin cancer	0.000578	0.0021	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—MC1R—skin cancer	0.000561	0.00204	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—MC1R—skin cancer	0.000552	0.002	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PTCH2—skin cancer	0.000552	0.002	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—MC1R—skin cancer	0.000549	0.00199	CbGpPWpGaD
Minaprine—ACHE—Metabolism—CSPG4—skin cancer	0.000537	0.00195	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—PTGER4—skin cancer	0.000518	0.00188	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—SHH—skin cancer	0.00051	0.00185	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—MC1R—skin cancer	0.00051	0.00185	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CSPG4—skin cancer	0.000506	0.00184	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—IL6—skin cancer	0.000503	0.00183	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—MC1R—skin cancer	0.000502	0.00182	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—MC1R—skin cancer	0.000499	0.00181	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—PTGER4—skin cancer	0.000489	0.00177	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—SMO—skin cancer	0.000484	0.00176	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—PTCH1—skin cancer	0.000484	0.00176	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—SHH—skin cancer	0.000481	0.00175	CbGpPWpGaD
Minaprine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.000478	0.00173	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PTCH2—skin cancer	0.000472	0.00171	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—PTGER4—skin cancer	0.000471	0.00171	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	0.000458	0.00166	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—SMO—skin cancer	0.000456	0.00166	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—PTCH1—skin cancer	0.000456	0.00166	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—TP53—skin cancer	0.000449	0.00163	CbGpPWpGaD
Minaprine—CHRM1—Regulation of Actin Cytoskeleton—NRAS—skin cancer	0.000446	0.00162	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—PTGER4—skin cancer	0.000444	0.00161	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—GLI2—skin cancer	0.000443	0.00161	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MC1R—skin cancer	0.000423	0.00154	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—PTGER4—skin cancer	0.000418	0.00152	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—GLI2—skin cancer	0.000418	0.00152	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—GLI1—skin cancer	0.000417	0.00151	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PTCH2—skin cancer	0.000416	0.00151	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—IL6—skin cancer	0.000412	0.0015	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—SHH—skin cancer	0.000412	0.00149	CbGpPWpGaD
Minaprine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000411	0.00149	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—IL6—skin cancer	0.000411	0.00149	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PTCH2—skin cancer	0.00041	0.00149	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PTCH2—skin cancer	0.000408	0.00148	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	0.000407	0.00148	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MC1R—skin cancer	0.000399	0.00145	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—SUFU—skin cancer	0.000395	0.00143	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—GLI1—skin cancer	0.000393	0.00143	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—PTCH1—skin cancer	0.00039	0.00142	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—SMO—skin cancer	0.00039	0.00142	CbGpPWpGaD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.000385	0.0014	CbGpPWpGaD
Minaprine—CHRM1—Regulation of Actin Cytoskeleton—KRAS—skin cancer	0.000384	0.00139	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—PTGER4—skin cancer	0.00038	0.00138	CbGpPWpGaD
Minaprine—ACHE—Transmission across Chemical Synapses—HRAS—skin cancer	0.000375	0.00136	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—SUFU—skin cancer	0.000373	0.00135	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—PTGER4—skin cancer	0.000369	0.00134	CbGpPWpGaD
Minaprine—ACHE—Metabolism—ENO2—skin cancer	0.000365	0.00132	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—TP53—skin cancer	0.000364	0.00132	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—SHH—skin cancer	0.000363	0.00132	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—PTGER4—skin cancer	0.000363	0.00132	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—PTGER4—skin cancer	0.000361	0.00131	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—GLI2—skin cancer	0.000358	0.0013	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—SHH—skin cancer	0.000357	0.0013	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—SHH—skin cancer	0.000355	0.00129	CbGpPWpGaD
Minaprine—MAOA—Transmission across Chemical Synapses—HRAS—skin cancer	0.000353	0.00128	CbGpPWpGaD
Minaprine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000349	0.00127	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—SMO—skin cancer	0.000344	0.00125	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—PTCH1—skin cancer	0.000344	0.00125	CbGpPWpGaD
Minaprine—MAOA—Metabolism—ENO2—skin cancer	0.000344	0.00125	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MC1R—skin cancer	0.000341	0.00124	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—PTCH1—skin cancer	0.000339	0.00123	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—SMO—skin cancer	0.000339	0.00123	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—SMO—skin cancer	0.000337	0.00122	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—PTCH1—skin cancer	0.000337	0.00122	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—GLI1—skin cancer	0.000336	0.00122	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—PTGER4—skin cancer	0.000335	0.00122	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.000335	0.00121	CbGpPWpGaD
Minaprine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000334	0.00121	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—IL6—skin cancer	0.000333	0.00121	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.000333	0.00121	CbGpPWpGaD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000332	0.0012	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—PTGER4—skin cancer	0.00033	0.0012	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—PTGER4—skin cancer	0.000328	0.00119	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—SUFU—skin cancer	0.000319	0.00116	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—GLI2—skin cancer	0.000316	0.00115	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—GLI2—skin cancer	0.000311	0.00113	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—GLI2—skin cancer	0.000309	0.00112	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—IL6—skin cancer	0.000303	0.0011	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—SHH—skin cancer	0.000301	0.00109	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MC1R—skin cancer	0.000301	0.00109	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—RASA1—skin cancer	0.000299	0.00109	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—GLI1—skin cancer	0.000297	0.00108	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MC1R—skin cancer	0.000296	0.00108	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MC1R—skin cancer	0.000295	0.00107	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—GLI1—skin cancer	0.000292	0.00106	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—GLI1—skin cancer	0.00029	0.00105	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000288	0.00105	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—HRAS—skin cancer	0.000287	0.00104	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000286	0.00104	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PTCH1—skin cancer	0.000286	0.00104	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—SMO—skin cancer	0.000286	0.00104	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.000285	0.00104	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—SHH—skin cancer	0.000284	0.00103	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—RASA1—skin cancer	0.000282	0.00103	CbGpPWpGaD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000282	0.00102	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—SUFU—skin cancer	0.000281	0.00102	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PTGER4—skin cancer	0.000278	0.00101	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—SUFU—skin cancer	0.000277	0.001	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—SUFU—skin cancer	0.000275	0.000999	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—TP53—skin cancer	0.000275	0.000997	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PLIN2—skin cancer	0.000273	0.000992	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—HRAS—skin cancer	0.000271	0.000982	CbGpPWpGaD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.00027	0.00098	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PTCH1—skin cancer	0.000269	0.000978	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—SMO—skin cancer	0.000269	0.000978	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—TP53—skin cancer	0.000269	0.000975	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PTGER4—skin cancer	0.000262	0.000952	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—IL6—skin cancer	0.000251	0.000912	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—IL6—skin cancer	0.000246	0.000893	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—FOXO4—skin cancer	0.000246	0.000892	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000245	0.000889	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000244	0.000884	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—SHH—skin cancer	0.000243	0.000882	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—RASA1—skin cancer	0.000242	0.000877	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000234	0.000851	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000233	0.000846	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—FOXO4—skin cancer	0.000232	0.000841	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PTCH1—skin cancer	0.00023	0.000837	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—SMO—skin cancer	0.00023	0.000837	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PTGER4—skin cancer	0.000224	0.000814	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CSPG4—skin cancer	0.00022	0.000799	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—SHH—skin cancer	0.000215	0.000779	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—RASA1—skin cancer	0.000213	0.000774	CbGpPWpGaD
Minaprine—ACHE—Metabolism—ERCC2—skin cancer	0.000212	0.000769	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—SHH—skin cancer	0.000211	0.000766	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—SHH—skin cancer	0.00021	0.000762	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—RASA1—skin cancer	0.00021	0.000762	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—RASA1—skin cancer	0.000209	0.000757	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—SMO—skin cancer	0.000203	0.000738	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PTCH1—skin cancer	0.000203	0.000738	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—SMO—skin cancer	0.0002	0.000726	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PTCH1—skin cancer	0.0002	0.000726	CbGpPWpGaD
Minaprine—MAOA—Metabolism—ERCC2—skin cancer	0.0002	0.000725	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PTCH1—skin cancer	0.000199	0.000723	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—SMO—skin cancer	0.000199	0.000723	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—FOXO4—skin cancer	0.000198	0.000719	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PTGER4—skin cancer	0.000198	0.000719	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PTGER4—skin cancer	0.000195	0.000707	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PTGER4—skin cancer	0.000194	0.000703	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—FOXO4—skin cancer	0.000175	0.000635	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—FOXO4—skin cancer	0.000172	0.000625	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—FOXO4—skin cancer	0.000171	0.000621	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TERT—skin cancer	0.000164	0.000596	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TERT—skin cancer	0.000155	0.000562	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ENO2—skin cancer	0.00015	0.000543	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—NRAS—skin cancer	0.000138	0.000502	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TERT—skin cancer	0.000132	0.00048	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—NRAS—skin cancer	0.00013	0.000473	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—BRAF—skin cancer	0.00013	0.000472	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PTGS2—skin cancer	0.000127	0.000461	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—BRAF—skin cancer	0.000123	0.000445	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PTGS2—skin cancer	0.00012	0.000435	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—KRAS—skin cancer	0.000119	0.000432	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TERT—skin cancer	0.000117	0.000424	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TERT—skin cancer	0.000115	0.000417	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TERT—skin cancer	0.000114	0.000415	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—KRAS—skin cancer	0.000112	0.000407	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—NRAS—skin cancer	0.000112	0.000405	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—BRAF—skin cancer	0.000105	0.000381	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—HRAS—skin cancer	0.000101	0.000367	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—NRAS—skin cancer	9.84e-05	0.000357	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—NRAS—skin cancer	9.68e-05	0.000352	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—IL6—skin cancer	9.68e-05	0.000351	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—NRAS—skin cancer	9.63e-05	0.00035	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—KRAS—skin cancer	9.6e-05	0.000348	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—HRAS—skin cancer	9.54e-05	0.000346	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—BRAF—skin cancer	9.25e-05	0.000336	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—IL6—skin cancer	9.13e-05	0.000331	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—BRAF—skin cancer	9.1e-05	0.00033	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—BRAF—skin cancer	9.05e-05	0.000329	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ERCC2—skin cancer	8.69e-05	0.000316	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—KRAS—skin cancer	8.47e-05	0.000307	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—KRAS—skin cancer	8.33e-05	0.000303	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—KRAS—skin cancer	8.29e-05	0.000301	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—NRAS—skin cancer	8.17e-05	0.000296	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—HRAS—skin cancer	8.16e-05	0.000296	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—IL6—skin cancer	7.81e-05	0.000283	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NRAS—skin cancer	7.7e-05	0.00028	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—HRAS—skin cancer	7.2e-05	0.000261	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—HRAS—skin cancer	7.08e-05	0.000257	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—HRAS—skin cancer	7.05e-05	0.000256	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—KRAS—skin cancer	7.03e-05	0.000255	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—IL6—skin cancer	6.89e-05	0.00025	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—IL6—skin cancer	6.78e-05	0.000246	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—IL6—skin cancer	6.74e-05	0.000245	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—KRAS—skin cancer	6.63e-05	0.000241	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NRAS—skin cancer	6.59e-05	0.000239	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TP53—skin cancer	6.25e-05	0.000227	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—HRAS—skin cancer	5.97e-05	0.000217	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TP53—skin cancer	5.89e-05	0.000214	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NRAS—skin cancer	5.81e-05	0.000211	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NRAS—skin cancer	5.72e-05	0.000208	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IL6—skin cancer	5.72e-05	0.000208	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NRAS—skin cancer	5.69e-05	0.000207	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—KRAS—skin cancer	5.67e-05	0.000206	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HRAS—skin cancer	5.63e-05	0.000205	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IL6—skin cancer	5.39e-05	0.000196	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PTGS2—skin cancer	5.21e-05	0.000189	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TP53—skin cancer	5.04e-05	0.000183	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—KRAS—skin cancer	5e-05	0.000182	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—KRAS—skin cancer	4.92e-05	0.000179	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—KRAS—skin cancer	4.9e-05	0.000178	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HRAS—skin cancer	4.82e-05	0.000175	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IL6—skin cancer	4.61e-05	0.000167	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TP53—skin cancer	4.45e-05	0.000161	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TP53—skin cancer	4.38e-05	0.000159	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TP53—skin cancer	4.35e-05	0.000158	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HRAS—skin cancer	4.25e-05	0.000154	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HRAS—skin cancer	4.18e-05	0.000152	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HRAS—skin cancer	4.16e-05	0.000151	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IL6—skin cancer	4.07e-05	0.000148	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IL6—skin cancer	4.01e-05	0.000145	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IL6—skin cancer	3.98e-05	0.000145	CbGpPWpGaD
